Strategic risk is often overlooked within the pharmaceutical industry. There's a perception that someone else is picking up the risk ball. Or there is more of a focus on internal risks, with little thought to the larger external factors that can have a significant impact on your launch. We see common risks arise from competitor launches, multi-indication launches, and supply chain issues. Unmitigated risks can lead to costly delays. So, what can you do to identify the risks for your asset launch and successfully mitigate them? In our latest Launch Excellence Alchemy podcast, our team of experts discuss and share their thoughts, tips, and solutions, with a focus on:

• The common strategic risks that arise during the launch of an asset
• Why it's important to create a strategic risk system to monitor these risks
• Creating an appropriate plan to mitigate risks and identifying who is accountable

Join John Crick, Launch Excellence Project Lead, Penny Matthews, Managing Consultant for Ignite™, and Andrew Coates, Risk Management Expert as they share ideas to think outside the box when it comes to risk management.